2
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Phenomenology of and Risk Factors for New-Onset Diabetes Mellitus and Diabetic Ketoacidosis Associated With Atypical Antipsychotics: An Analysis of 45 Published Cases

, &
Pages 59-64 | Published online: 04 Dec 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Marco Solmi, Andrea Murru, Isabella Pacchiarotti, Juan Undurraga, Nicola Veronese, Michele Fornaro, Brendon Stubbs, Francesco Monaco, Eduard Vieta, Mary V Seeman, Christoph U Correll & André F Carvalho. (2017) Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Therapeutics and Clinical Risk Management 13, pages 757-777.
Read now
Yuki Fujii, Hanae Ida, Tatsushi Shimokuni & Fumihiko Haraguchi. (2017) Treatment of nausea with innovative antiemetics. Expert Review of Quality of Life in Cancer Care 2:2, pages 109-121.
Read now
Ann O. Scheimann. (2012) Overview of paediatric obesity for the paediatric mental health provider. International Review of Psychiatry 24:3, pages 231-240.
Read now
Joshua T Kantrowitz & Leslie Citrome. (2008) Olanzapine: review of safety 2008. Expert Opinion on Drug Safety 7:6, pages 761-769.
Read now
DG Van Zyl. (2008) Diagnosis and treatment of diabetic ketoacidosis. South African Family Practice 50:1, pages 35-39.
Read now
Lauren Shin, Hallie Bregman, Jean Frazier & Nancy Noyes. (2008) An Overview of Obesity in Children with Psychiatric Disorders Taking Atypical Antipsychotics. Harvard Review of Psychiatry 16:2, pages 69-79.
Read now
James W Michelsen & Jonathan M Meyer. (2007) Cardiovascular effects of antipsychotics. Expert Review of Neurotherapeutics 7:7, pages 829-839.
Read now
Chanoch Miodownik & Vladimir Lerner. (2006) Quetiapine: efficacy, tolerability and safety in schizophrenia. Expert Review of Neurotherapeutics 6:7, pages 983-992.
Read now
Krishnan Ramaswamy, Prakash S. Masand & Henry A. Nasrallah. (2006) Do Certain Atypical Antipsychotics Increase the Risk of Diabetes? A Critical Review of 17 Pharmacoepidemiologic Studies. Annals of Clinical Psychiatry 18:3, pages 183-194.
Read now
Frank Gianfrancesco, Ruey-Hua Wang & Henry A. Nasrallah. (2006) The Influence of Study Design on the Results of Pharmacoepidemiologic Studies of Diabetes Risk With Antipsychotic Therapy. Annals of Clinical Psychiatry 18:1, pages 9-17.
Read now
Arshia A. Shirzadi & S. Nassir Ghaemi. (2006) Side Effects of Atypical Antipsychotics: Extrapyramidal Symptoms and the Metabolic Syndrome. Harvard Review of Psychiatry 14:3, pages 152-164.
Read now
Peter Schwenkreis & Hans-jörg Assion. (2004) Atypical antipsychotics and diabetes mellitus. The World Journal of Biological Psychiatry 5:2, pages 73-82.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.